Jane Street’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
ACA
DCM
JT
Jane Street's DFTX Position: Q2 2026 in Review
Jane Street sold out of Definium Therapeutics (DFTX) in Q2 2026, closing a stake of 260,241 shares — an estimated $6.43M sold.
Jane Street first reported a position in DFTX in Q2 2021 and held it in 17 quarters. The position peaked at $7.18M in Q4 2025. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.
- Jane Street reported no remaining Definium Therapeutics position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 260,241 Definium Therapeutics shares in Q2 2026, an estimated $6.43M.
- Jane Street first reported a position in Definium Therapeutics in Q2 2021 and held it in 17 quarters.
- Jane Street's Definium Therapeutics position peaked at $7.18M in Q4 2025.
- 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.